Molecular Insights into Zoonotic Diseases
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Microbiology".
Deadline for manuscript submissions: 31 January 2025 | Viewed by 789
Special Issue Editor
Interests: mycobacterial diseases; tuberculosis; host immune responses; pathogenesis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Infectious diseases continue to ravage human lives, causing significant morbidity and mortality worldwide. Tuberculosis (TB) caused by Mycobacterium tuberculosis (M. tb) is believed to have been in existence for several thousand years. TB continues to cause 2 million deaths every year and 10 million new cases annually worldwide.
Zoonotic tuberculosis (TB) is a form of TB in people caused by Mycobacterium bovis, which belongs to the M. tb complex. It often affects sites other than the lungs (extrapulmonary), but in many cases, it is clinically indistinguishable from TB caused by M. tb. Within animal populations, M. bovis is the causative agent of bovine TB. It mainly affects cattle, which are the most important animal reservoir, and can become established in wildlife. The disease results in important economic losses and trade barriers with a major impact on the livelihoods of poor and marginalized communities.
M. marinum, an atypical mycobacterium and a causative agent of fish tank granuloma, is transmitted from fish to humans. The ongoing pandemic has resulted in the neglect of several infectious diseases including TB and malaria. As the world tries to emerge from the pandemic, it is important to ensure that the entire world has access to health care to prevent future pandemics.
This Special Issue is dedicated to molecular-level research on host-pathogen interactions, pathogenesis, and the mechanisms of acute and chronic infections, with a focus on zoonotic diseases. We encourage submissions that explore the molecular aspects of human-animal interactions and the transmission of bacteria and viruses from animals to humans.
We welcome articles on the most recent advances in the discovery of novel therapeutic compounds and repurposed drugs that can potentially be utilized against infectious agents.We also invite submissions on preclinical and clinical research findings obtained from mechanistic studies. Since IJMS is a journal of molecular science, purely clinical studies and epidemiology will not suitable. However, clinical or pure model submissions with biomolecular experiments are welcomed.
Prof. Dr. Vishwanath Venketaraman
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- mycobacterial diseases
- bubonic and pneumonic plague
- Q fever
- cat scratch disease
- Mediterranean fever
- HIV
- malaria
- ADIS
- SARS-CoV-2
- adjunctive therapy
- immune-enhancing agents
- antimycobacterial compounds
- host-directed therapies
- pathogenesis
- modulation of host immune responses
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
